Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Covetrus stock
Learn how to easily invest in Covetrus stock.
Covetrus Inc is a medical distribution business based in the US. Covetrus shares (CVET) are listed on the NASDAQ and all prices are listed in US Dollars. Covetrus employs 4,035 staff and has a trailing 12-month revenue of around $4.6 billion.
How to buy shares in Covetrus
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CVET – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Covetrus stock price (NASDAQ: CVET)Use our graph to track the performance of CVET stocks over time.
Covetrus shares at a glance
|Latest market close||$20.88|
|52-week range||$13.39 - $21.20|
|50-day moving average||$20.83|
|200-day moving average||$18.74|
|Wall St. target price||$21.33|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.30|
Buy Covetrus shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Covetrus stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Covetrus price performance over time
|1 week (2022-09-23)||0.05%|
|1 month (2022-08-30)||N/A|
|3 months (2022-07-01)||0.14%|
|6 months (2022-04-01)||22.75%|
|1 year (2021-10-01)||12.99%|
|2 years (2020-10-02)||-14.60%|
|3 years (2019-10-03)||82.12%|
|5 years (2017-09-29)||N/A|
Is Covetrus stock undervalued or overvalued?
Valuing Covetrus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Covetrus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Covetrus's PEG ratio
Covetrus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3326. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Covetrus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Covetrus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $174 million.
The EBITDA is a measure of a Covetrus's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4.6 billion|
|Operating margin TTM||0.17%|
|Gross profit TTM||$858 million|
|Return on assets TTM||0.15%|
|Return on equity TTM||-0.85%|
|Market capitalisation||$2.9 billion|
TTM: trailing 12 months
Covetrus share dividends
We're not expecting Covetrus to pay a dividend over the next 12 months.
Covetrus share price volatility
Over the last 12 months, Covetrus's shares have ranged in value from as little as $13.39 up to $21.2. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Covetrus's is 1.6329. This would suggest that Covetrus's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Covetrus, Inc. , together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions, such as inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software, data-driven applications, client communications tools, and related services to increase staff efficiency and enhance business health; and solutions that integrate with its software platforms, including client communication services, reminders, data backup services, hardware sales and support, and credit card processing services for veterinary practitioners and animal-health clinics. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as offers shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal, equine, and large-animal markets primarily in North America, Europe, and the Asia Pacific.
Covetrus in the news
Johnson Fistel Announces Investigation of the Proposed Sale of Covetrus
Covetrus Names Michelle Bonfilio as Chief People Officer
Moody's assigns B2 CFR to Covetrus, Inc.; Outlook Stable
Frequently asked questionsWhat percentage of Covetrus is owned by insiders or institutions?
Currently 0.628% of Covetrus shares are held by insiders and 95.019% by institutions. How many people work for Covetrus?
Latest data suggests 4,035 work at Covetrus. When does the fiscal year end for Covetrus?
Covetrus's fiscal year ends in December. Where is Covetrus based?
Covetrus's address is: 7 Custom House Street, Portland, ME, United States, 04101 What is Covetrus's ISIN number?
Covetrus's international securities identification number is: US22304C1009 What is Covetrus's CUSIP number?
Covetrus's Committee on Uniform Securities Identification Procedures number is: 22304C100
More guides on Finder
Alternatives to Webull
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Best renewable energy stocks for 2022
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
The best dividend stocks for 2022
Our list of 10 dividend stocks to watch in 2022.
How to buy YanGuFang International Group (YGF) stock when it goes public
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
What are the FAANG stocks and how do you invest in them?
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
How to buy soccer stocks
A simple guide to buying stocks in your favorite European soccer team.
How to buy Juventus stock
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
How to buy AS Roma stock
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
How to buy Borussia Dortmund stock
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.
Ask an Expert